Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, Burtness B, Ghi MG, Cohen EEW, Grau C, Wolf G, Hitt R, Corvò R, Budach V, Kumar S, Laskar SG, Mazeron JJ, Zhong LP, Dobrowsky W, Ghadjar P, Fallai C, Zakotnik B, Sharma A, Bensadoun RJ, Ruo Redda MG, Racadot S, Fountzilas G, Brizel D, Rovea P, Argiris A, Nagy ZT, Lee JW, Fortpied C, Harris J, Bourhis J, Aupérin A, Blanchard P, Pignon JP; MACH-NC Collaborative Group. Lacas B, et al. Among authors: licitra l. Radiother Oncol. 2021 Mar;156:281-293. doi: 10.1016/j.radonc.2021.01.013. Epub 2021 Jan 27. Radiother Oncol. 2021. PMID: 33515668 Free PMC article.
Cancer of the oropharynx.
Licitra L, Bernier J, Grandi C, Merlano M, Bruzzi P, Lefebvre JL. Licitra L, et al. Crit Rev Oncol Hematol. 2002 Jan;41(1):107-22. doi: 10.1016/s1040-8428(01)00129-9. Crit Rev Oncol Hematol. 2002. PMID: 11796235 Review.
Cancer of the larynx.
Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, Lefebvre JL. Licitra L, et al. Crit Rev Oncol Hematol. 2003 Jul;47(1):65-80. doi: 10.1016/s1040-8428(03)00017-9. Crit Rev Oncol Hematol. 2003. PMID: 12853099 Review.
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M, Tomatis S, Orlandi E, Guzzo M, Sangalli C, Potepan P, Fantini S, Bergamini C, Gavazzi C, Licitra L, Scaramellini G, Cantu' G, Olmi P. Palazzi M, et al. Among authors: licitra l. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):330-7. doi: 10.1016/j.ijrobp.2007.06.022. Epub 2007 Sep 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 17881148
Biological agents in head and neck cancer.
Bossi P, Locati LD, Licitra L. Bossi P, et al. Among authors: licitra l. Expert Rev Anticancer Ther. 2007 Nov;7(11):1643-50. doi: 10.1586/14737140.7.11.1643. Expert Rev Anticancer Ther. 2007. PMID: 18020930 Review.
Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience.
Palazzi M, Orlandi E, Bossi P, Pignoli E, Potepan P, Guzzo M, Franceschini M, Scaramellini G, Cantù G, Licitra L, Olmi P, Tomatis S. Palazzi M, et al. Among authors: licitra l. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):774-80. doi: 10.1016/j.ijrobp.2008.08.068. Epub 2009 Feb 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19250771
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].
Stewart JS, Cohen EE, Licitra L, Van Herpen CM, Khorprasert C, Soulieres D, Vodvarka P, Rischin D, Garin AM, Hirsch FR, Varella-Garcia M, Ghiorghiu S, Hargreaves L, Armour A, Speake G, Swaisland A, Vokes EE. Stewart JS, et al. Among authors: licitra l. J Clin Oncol. 2009 Apr 10;27(11):1864-71. doi: 10.1200/JCO.2008.17.0530. Epub 2009 Mar 16. J Clin Oncol. 2009. PMID: 19289630 Clinical Trial.
440 results